You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大行評級|花旗:上調鉅子生物目標價至68.2港元 加快新產品上市建立專業品牌形象
格隆匯 02-20 16:24
花旗發表研報指,鉅子生物近日推出了一個新的產品系列“幀域密修”,該系列以其新的專利重組膠原蛋白成分,針對熱損傷後的肌膚護理,尤其是光電治療後的護理,令鉅子生物的修護產品線從基礎和一般修護,拓展到更專業及精準護理領域,有助帶來新收入來源、鞏固其以科學爲導向的產品定位,並建立了專業品牌形象。花旗相信,鉅子生物是消費者對產品科學性的重視日益增長以及對肌膚修護需求不斷上升的主要受益者,給予“買入”評級,基於2025年預測市盈率約25倍,將目標價由61港元上調至68.2港元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account